Systemic Administration of Soluble Glycoprotein 130 in Traumatic Brain Injury: Effects on Cognitive Performance and Chemokine Levels
Research Review: Treating Traumatic Brain Injury through Selective Inhibition of IL-6 Pathway Background Traumatic brain injury (TBI) is one of the leading causes of long-term neurological damage and death globally, with no effective disease-modifying treatments currently available. TBI patients often suffer from cognitive, behavioral, and sensory ...